MEREDITH STEVENS: Open Payments
NPI 1245004514 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 14 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 1 | $150 |
| Otter Pharmaceuticals, LLC | 6 | $115 |
| Aucta Pharmaceuticals, Inc. | 4 | $59 |
| UCB, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Yorvipath, SYMPAZAN, Motpoly XR, Fintepla, REXULTI.
Industry payments across NY — which companies pay providers there.
